Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 173 of 1,261
  1. US 11746151

    Compositions and methods for treating cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  2. US 11746152

    Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1

    The Board of Regents of the University of Texas System Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  3. US 11744926

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  4. US 11744790

    Compositions and methods for blocking ultraviolet radiation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  5. US 11746087

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  6. US 11744800

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Heron Therapeutics, Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  7. US 11738085

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  8. US 11739137

    Single domain antibodies to SARS-CoV-2 nucleocapsid protein

    The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  9. US 11739294

    Compositions and methods for treating retinal diseases

    The Regents of the University of California Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  10. US 11739068

    Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof

    KalVista Pharmaceuticals Limited Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  11. US 11737983

    Storage stable sincalide formulations

    MAIA PHARMACEUTICALS, INC. Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  12. US 11739133

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  13. US 11738116

    Expanded nanofiber structures comprising electrospun nanofibers and a plurality of holes and methods of making and use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  14. US 11739132

    Separation moieties and methods of use thereof

    Werewolf Therapeutics, Inc. Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  15. US 11739123

    Process for the preparation of cyclic depsipeptides

    OnKure, Inc. Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  16. US 11739121

    EPHA2 agonists and uses thereof

    The Regents of the University of California Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  17. US 11737979

    Method of making lipid-encapsulated RNA nanoparticles

    ARCTURUS THERAPEUTICS, INC. Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  18. US 11737978

    Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease

    Northwestern University Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  19. US 11738035

    Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

    Compass Pathfinder Limited Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  20. US 11738038

    Highly active compounds against COVID-19

    Atea Pharmaceuticals, Inc. Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  21. US 11739063

    DREADD actuators

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  22. US 11737981

    Cellulosic polymer nanoparticles and methods of forming them

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  23. US 11738022

    Methods for inducing pupil dilation

    The Regents of the University of Colorado, a Body Corporate Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted
  24. US 11738019

    Substituted heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. Β· Granted Aug 29, 2023 Β· Expires Aug 24, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.